sec filings
Insiders
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
LYCA
Updated Nov 3, 2026, 9:02 AM ET
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Filing |
|---|---|---|---|---|---|---|---|
| LYCA Lycia Therapeutics, Inc. | Buy | $644,711$644,711 | Venrock Healthcare Capital Partners III, L.P. · 10% owner · and 8 others 10% owner and 8 others | 25,004 sh | · at $25.78 | · Oct 30Oct 30, 7:25 PM ET | · Filing |
| LYCA Lycia Therapeutics, Inc. | Buy | $37.65M$37,653,863 | Venrock Healthcare Capital Partners III, L.P. · 10% owner · and 8 others 10% owner and 8 others | 2,045,440 sh | · at $18.41 | · Oct 27Oct 27, 6:38 PM ET | · Filing |